These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 24424197)

  • 21. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
    Jarius S; Wildemann B
    Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromyelitis optica.
    Wingerchuk DM
    Int MS J; 2006 May; 13(2):42-50. PubMed ID: 16635421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.
    Domingos J; Isidoro L; Figueiredo R; Brum M; Capela C; Barros P; Santos E; Macário Mdo C; Pinto Marques J; Pedrosa R; Vale J; Sá MJ
    Clin Neurol Neurosurg; 2015 Jul; 134():79-84. PubMed ID: 25965287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
    Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMO-IgG: a specific biomarker for neuromyelitis optica.
    Weinshenker BG; Wingerchuk DM; Pittock SJ; Lucchinetti CF; Lennon VA
    Dis Markers; 2006; 22(4):197-206. PubMed ID: 17124341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
    Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
    J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromyelitis optica pathogenesis and aquaporin 4.
    Graber DJ; Levy M; Kerr D; Wade WF
    J Neuroinflammation; 2008 May; 5():22. PubMed ID: 18510734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromyelitis Optica Spectrum Disorders.
    Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
    Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuromyelitis optica: a clinical update].
    Chiquete E; Navarro-Bonnet J; Ayala-Armas R; Gutiérrez-Gutiérrez N; Solórzano-Meléndez A; Rodríguez-Tapia D; Gómez-Rincón M; Ruiz-Sandoval JL
    Rev Neurol; 2010 Sep; 51(5):289-94. PubMed ID: 20669128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.
    Siuko M; Tienari PJ; Saastamoinen KP; Atula S; Miettinen A; Kivelä T; Setälä K
    Acta Ophthalmol; 2014 Jun; 92(4):387-91. PubMed ID: 23773223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker.
    Weinshenker BG; Wingerchuk DM
    Curr Top Microbiol Immunol; 2008; 318():343-56. PubMed ID: 18219825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuromyelitis optica presenting with horner syndrome: A case report and review of literature.
    Uludağ İF; Sarıteke A; Öcek L; Zorlu Y; Şener U; Tokuçoğlu F; Uludağ B
    Mult Scler Relat Disord; 2017 May; 14():32-34. PubMed ID: 28619428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromyelitis Optica-AQP4: an update.
    Benavente E; Paira S
    Curr Rheumatol Rep; 2011 Dec; 13(6):496-505. PubMed ID: 21922173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis.
    Petzold A; Pittock S; Lennon V; Maggiore C; Weinshenker BG; Plant GT
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):109-11. PubMed ID: 20019228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders.
    Jarius S; Franciotta D; Bergamaschi R; Wildemann B; Wandinger KP
    Clin Chem Lab Med; 2010 May; 48(5):659-63. PubMed ID: 20184532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic criteria and differential diagnosis of neuromyelitis optica].
    Nakashima I
    Nihon Rinsho; 2014 Nov; 72(11):1964-9. PubMed ID: 25518378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
    Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
    Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Devic's syndrome and primary APS: a new immunological overlap.
    Squatrito D; Colagrande S; Emmi L
    Lupus; 2010 Oct; 19(11):1337-9. PubMed ID: 20504834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-aquaporin-4 antibodies in the context of assorted immune-mediated diseases.
    Dellavance A; Alvarenga RR; Rodrigues SH; Kok F; de Souza AW; Andrade LE
    Eur J Neurol; 2012 Feb; 19(2):248-52. PubMed ID: 21771203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients.
    Ketelslegers IA; Modderman PW; Vennegoor A; Killestein J; Hamann D; Hintzen RQ
    Mult Scler; 2011 Dec; 17(12):1527-30. PubMed ID: 21828202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.